139 related articles for article (PubMed ID: 7627628)
41. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
Campos KR; Gonçalves MG; Costa NA; Caterino-de-Araujo A
Braz J Infect Dis; 2017; 21(3):297-305. PubMed ID: 28343818
[TBL] [Abstract][Full Text] [Related]
42. Licensure of screening tests for antibody to human T-lymphotropic virus type I.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Dec; 37(48):736-40, 745-7. PubMed ID: 3143058
[No Abstract] [Full Text] [Related]
43. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
44. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
[TBL] [Abstract][Full Text] [Related]
45. Low human T cell leukemia virus type II seroprevalence in Africa.
Bonis J; Verdier M; Dumas M; Denis F
J Infect Dis; 1994 Jan; 169(1):225-7. PubMed ID: 8277189
[No Abstract] [Full Text] [Related]
46. Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients.
Lin MT; Nguyen BT; Binh TV; Be TV; Chiang TY; Tseng LH; Yang YC; Lin KH; Chen YC
Arch Virol; 1997; 142(7):1429-40. PubMed ID: 9267453
[TBL] [Abstract][Full Text] [Related]
47. A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
Vranckx R; Coenjaert A; Muylle L
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):827-30. PubMed ID: 2390333
[TBL] [Abstract][Full Text] [Related]
48. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
Dipierri JE; Tajima K; Cartier Robirosa L; Sonoda S
Medicina (B Aires); 1999; 59(6):717-20. PubMed ID: 10752214
[TBL] [Abstract][Full Text] [Related]
49. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
[No Abstract] [Full Text] [Related]
50. Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
Góngora-Biachi RA; González-Martínez P; Puerto FI; Bastarrachea-Ortíz J; Yamaguchi K; Nishimura Y; Takatsuki K
Rev Invest Clin; 1993; 45(3):281-2. PubMed ID: 8210771
[No Abstract] [Full Text] [Related]
51. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
Stramer SL; Foster GA; Dodd RY
Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
[TBL] [Abstract][Full Text] [Related]
52. [Expression of a fragment of the env gene, coding for the GP46 surface glycoprotein of the human T-cell leukemia virus, in Escherichia coli cells].
Bondarenko VO; Kazennova EV; Bobkova MR; Prilipov AG; Bobkov AF
Mol Gen Mikrobiol Virusol; 2000; (3):33-6. PubMed ID: 10975079
[TBL] [Abstract][Full Text] [Related]
53. Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.
Olaleye DO; Bernstein L; Sheng Z; Ekweozor CC; Li XY; Sullivan-Halley J; Rasheed S
Am J Trop Med Hyg; 1994 Apr; 50(4):479-86. PubMed ID: 8166356
[TBL] [Abstract][Full Text] [Related]
54. Human T lymphotropic virus 1-2 positive antibodies in potential organ donors in France.
Claquin J; Romano P; Noury D; Borsarelli J; Jacob F; Feuillerat JP; Colpart JJ
Transplant Proc; 1996 Feb; 28(1):189-90. PubMed ID: 8644172
[No Abstract] [Full Text] [Related]
55. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
56. Serologic discrimination of human T cell lymphotropic virus infection by using a synthetic peptide-based enzyme immunoassay.
Lal RB; Rudolph DL; Lairmore MD; Khabbaz RF; Garfield M; Coligan JE; Folks TM
J Infect Dis; 1991 Jan; 163(1):41-6. PubMed ID: 1984475
[TBL] [Abstract][Full Text] [Related]
57. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
Christiansen CB
Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528
[TBL] [Abstract][Full Text] [Related]
58. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
[TBL] [Abstract][Full Text] [Related]
59. [Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women].
Ramos JM; Milla A; Sánchez V; Vergés M; Toro C; Gutiérrez F
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):165-7. PubMed ID: 19306717
[TBL] [Abstract][Full Text] [Related]
60. HTLV-I/II antibodies among three different Indian groups from Paraguay.
de Cabral MB; Vera ME; Samudio M; Arias AR; Cabello A; Moreno R; Zapiola I; Bouzas MB; Muchinik G
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):548-9. PubMed ID: 9859972
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
